statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 2023 Singular Genomics Systems Inc Earnings Call Transcript

SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results

Singular Genomics Sys (NASDAQ:OMIC) anuncia su pr xima ronda de resultados este lunes, 18 de marzo. Este es el an lisis de Benzinga sobre el informe de ganancias del cuarto trimestre de Singular...

Avance de ganancias: Singular Genomics Sys

Singular Genomics Sys (NASDAQ:OMIC) pubblicher i prossimi risultati degli utili questo luned 18 marzo. Per tutte le informazioni in merito, ecco la tua guida sulla pubblicazione degli utili di...

Previsioni sugli utili di Singular Genomics Sys

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...

Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...

Singular Genomics Showcases New G4X  Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4  Sequencing Platform

Singular Genomics Unveils G4X  Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis

SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...

Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.

Watchers	304
52-Wk Low	$0.3101
52-Wk High	$1.14

Volume	189,110.00
52-Wk High	$1.14
52-Wk Low	$0.3101

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.30	--	--	N/A
Q1'24	-$0.34	-$0.34	-1.49%	MISSED
Q4'23	-$0.32	-$0.32	-0.69%	MISSED
Q3'23	-$0.38	-$0.31	18.67%	BEAT
Q2'23	-$0.36	-$0.35	1.59%	BEAT

OMIC Singular Genomics Systems Inc

About

Feed

News

Earnings

Fundamentals